EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment

Niaz Chalabianloo iD, Sheikh S Abdullah iD, Mohammad Ali Omrani iD, Atefeh Jafari iD, Kamran Sedig, Flory Tsobo Muanda iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0331940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Niaz Chalabianloo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Adverse Drug Reaction Reporting Systems, Data Accuracy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mitacs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Canada Vigilance Adverse Reaction database is a vital pharmacovigilance tool, but its utility is severely limited by heterogeneity in medication nomenclature. A substantial portion (∼36.8%) of unique drug name variants in the database lack any mapping to an active ingredient, representing a critical data quality gap that can mask important adverse drug reaction (ADR) signals.

Methods

We developed, validated, and publicly released a high-precision, automated pipeline to standardize and enrich medication names. The pipeline employs a cascaded matching strategy that leverages the RxNorm and Observational Health Data Sciences and Informatics (OHDSI) vocabularies. Standardized names are assigned a RxNorm Concept Unique Identifier (RxCUI) and enriched with active ingredient data and Anatomical Therapeutic Chemical (ATC) classifications via RxNav APIs. The pipeline’s accuracy was rigorously assessed by two independent experts on a balanced validation set of 200 cases.

Results

The final pipeline successfully standardized 94.5% of the 46,585 unique drug names. A blinded expert validation confirmed high reliability, demonstrating a precision of 98.02% (95% CI: 0.9307–0.9946) and specificity of 97.22% (95% CI: 0.9043–0.9923). Case studies showed that standardization and aggregation of reports revealed known safety signals (e.g., mesalamine and asthenia) that were statistically undetectable in the raw data.

Conclusion

Our transparent and reproducible pipeline effectively resolves medication name heterogeneity in Canada’s national ADR database. By transforming variable text into standardized concepts, it significantly enhances data quality, improves the sensitivity of safety signal detection, and facilitates interoperability with global health datasets. The publicly available tool provides a valuable resource for strengthening drug safety surveillance in Canada and beyond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsAdverse Drug Reaction Reporting SystemsData AccuracyCanadaHumansPharmacovigilanceDatabases, FactualTerminology as TopicReproducibility of Results

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, Western University, London, Ontario, Canada.
  • Department of Computer Science, Western University, London, Ontario, Canada.
  • ICES Western, London, Ontario, Canada.
  • Department of Computer Science, MacEwan University, Edmonton, Alberta, Canada.
  • London Health Sciences Centre Research Institute, London, Ontario, Canada.
  • Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.

ORCID-Profile: Niaz Chalabianloo, Sheikh S Abdullah, Mohammad Ali Omrani, Atefeh Jafari, Flory Tsobo Muanda

Förderung

  • Mitacs

Zitieren

APA

Chalabianloo, N., Abdullah, S. S., Omrani, M. A., Jafari, A., Sedig, K., & Muanda, F. T. (2025). Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment. PLOS One. https://doi.org/10.1371/journal.pone.0331940

Vancouver

Chalabianloo N, Abdullah SS, Omrani MA, Jafari A, Sedig K, Muanda FT. Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment. PLOS One. 2025. doi:10.1371/journal.pone.0331940

BibTeX
@article{Chalabianloo2025,
  author = {Chalabianloo, Niaz and Abdullah, Sheikh S and Omrani, Mohammad Ali and Jafari, Atefeh and Sedig, Kamran and Muanda, Flory Tsobo},
  title = {Enhancing adverse drug reaction data quality in Canada: A high-precision pipeline for medication name standardization and enrichment},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0331940}
}
Kostenlos starten →